Importance of Inhibin B in the Regulation of FSH Secretion in the Human Male 78k Journal of Clinical Endocrinology and Metabolism
Volume 86 • Number 11 • November 2001
Copyright © 2001 The Endocrine Society


5541

Other Original Articles


Importance of Inhibin B in the Regulation of FSH Secretion in the Human Male



FRANCES J. HAYES 1
NELLY PITTELOUD 1
SUZZUNNE DECRUZ 1
WILLIAM F. CROWLEY JR. 1
PAUL A. BOEPPLE 1


1 Reproductive Endocrine Unit, Department of Medicine, and National Center for Infertility Research, Massachusetts General Hospital, Boston, Massachusetts 02114


Received February 2, 2001.
Accepted August 15, 2001.

Address all correspondence and requests for reprints to: Frances Hayes, M.B., M.R.C.P.I., Reproductive Endocrine Unit and National Center for Infertility Research, Massachusetts General Hospital, Fruit Street, Boston, Massachusetts 02114. E-mail: hayes.frances@mgh. harvard.edu.

This work was supported in part by Grants R01-HD-15788-15, DK07028-24, P30-HD-28138, and M01-RR-01066. Presented in part at the 82nd Annual Meeting of The Endocrine Society, Toronto, Canada, 2000.

Copyright © 2001 by The Endocrine Society



Abbreviations:

CV,
Coefficient of variation;
FAS,
free α-subunit;;
Inh B,
inhibin B;;
IPI,
interpulse interval;;
NL,
normal.

Regulation of FSH secretion in the male involves a complex balance between stimulation by GnRH from the hypothalamus, inhibitory feedback by sex steroids (T and E2) and inhibin B (Inh B) from the gonads, and autocrine/paracrine modulation by activin and follistatin within the pituitary. The aim of the present study was to delineate the feedback control of FSH in the human male with specific reference to the relative roles of sex steroids vs. Inh B. Two experimental human models were used: 1) normal (NL) men subjected to acute sex steroid withdrawal (−T, −E2, + Inh B), and 2) functional castrate males (−T, −E2, −Inh B).

Nine NL men (age range, 25–45 yr) and three castrate males (age range, 23–47 yr) were studied. The NL men underwent acute sex steroid suppression using high dose ketoconazole (1-g loading dose, followed by 400 mg, orally, four times daily for 150 h). Gonadotropin secretion was characterized by frequent blood sampling every 10 min for 12 h at baseline and on d 3 and 6 of sex steroid ablation. In the three castrate subjects, blood sampling was performed every 5 min for 24 h 8 wk after discontinuing androgen replacement therapy.

In the NL men, treatment with ketoconazole resulted in a decline to castrate levels in T (451 ± 20 to 38 ± 7 ng/dl; P < 0.0005) and E2 (39 ± 4 to 15 ± 2 pg/ml; P < 0.005) and a modest, but significant, decline in Inh B levels, which remained within the normal range (183 ± 19 to 136 ± 13 pg/ml; P < 0.005). This suppression of sex steroids was associated with a more marked increase in mean LH (9.5 ± 0.9 to 24.9 ± 2.0 IU/liter; P < 0.0001) than FSH levels (5.1 ± 0.7 to 10.0 ± 1.5 IU/liter; P < 0.005), with the latter not exceeding the normal adult male range. The castrate subjects had a mean T level of 66 ± 8 ng/dl, an E2 level of 20 ± 1 pg/ml, and undetectable Inh B levels. Despite a similar sex steroid milieu, the mean FSH levels observed in NL men after acute sex steroid ablation were approximately 6-fold lower than those seen in the castrate subjects (10.0 ± 1.5 vs. 59.5 ± 17.7 IU/liter; P < 0.0005). In contrast, mean LH levels in the NL men were less than 3-fold lower than those in castrate subjects (24.9 ± 2.0 vs. 66.8 ± 20.1 IU/liter; P < 0.005).

From this human model of acute sex steroid withdrawal, we conclude that Inh B is likely to be the major feedback regulator of FSH secretion in the human male. ( J Clin Endocrinol Metab 86: 5541–5546, 2001)


IN THE UNITED States, 10–15% of couples are infertile, with a male factor implicated in up to 50% of cases [1] . To date, the etiology of most cases of male infertility remains poorly understood, with inconsistent elevation of FSH levels. Indeed, the role of FSH in both the initiation and the maintenance of spermatogenesis is controversial and exhibits important species differences [2] [3] [4] [5] [6] . In male mice rendered FSH deficient due to targeted disruption of the FSH β-subunit [2] or FSH receptor gene [3] , fertility is preserved despite reduced testes size and partial spermatogenic failure. In the human there is discordance between the phenotype of men with mutations in the FSH receptor gene who are oligospermic [4] and those with mutations of the FSH β-subunit who are azoospermic [5] [6] . This discrepancy in the degree of spermatogenic failure suggests that ligand deficiency may well have a more severe expression than that of the FSH receptor and raises question about the completeness of the receptor knockout models. Given these human data indicating that FSH is required for quantitatively normal spermatogenesis, delineating the feedback regulation of FSH is key to defining the pathophysiology of male infertility as well as determining the feasibility of hormonal approaches to male contraception.

It has long been known that regulation of gonadotropin secretion in the human male involves a complex interplay between stimulation by GnRH secretion and inhibitory feedback by sex steroids comprising T and E2 from Leydig cells. However, in the last decade it has also been increasingly appreciated that for FSH, there is an additional level of complexity mediated by nonsteroidal factors. This nonsteroidal regulation of FSH comprises an endocrine negative feedback loop mediated by inhibin B (Inh B) secretion from Sertoli cells [7] [8] [9] [10] [11] [12] [13] in addition to autocrine/paracrine modulation within the pituitary mediated by activin and follistatin [14] . Thus, an integrated approach to the study of FSH regulation requires utilization of models that permit isolation of the effects of sex steroids from those of nonsteroidal factors.

To date, most clinical investigation in the human has addressed only the sex steroid component of gonadal feedback [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . However, the nonsteroidal component of gonadal feedback is particularly important given that most cases of male infertility represent a defect in the seminiferous tubule compartment of the testis in the absence of any obvious perturbation in Leydig cell function. It has only recently been possible to quantitate the biologically active nonsteroidal gonadal regulators of FSH reliably with the development of sensitive and specific assays for Inh B [25] . To date, inhibin has not been available in sufficient purity or quantity for human administration; thus, for the present, studies on inhibin


5542
physiology in the human must remain inferential. In terms of the GnRH component to FSH regulation in the male, available data are limited to normal men with intact gonadal negative feedback. Although manipulation of GnRH pulse frequency has been shown to have little impact on serum FSH levels in the setting of a gonadally intact male [26] [27] [28] , the effect of GnRH pulse frequency on FSH in the absence of gonadal feedback has not been determined.

Thus, in the present experiments we set out to elucidate the Inh B contribution to FSH regulation by comparing the FSH levels of normal men after acute sex steroid withdrawal with those in age-matched functional castrates who lack both sex steroids and Inh B. We hypothesized that suppression of sex steroid negative feedback to castrate levels would fail to recreate castrate levels of FSH in an Inh B-replete model, implying that Inh B is the major regulator of FSH secretion in the human male. We also hypothesized that Inh B would have no effect on GnRH pulse frequency, such that despite markedly different Inh B levels, similar pulse frequencies would be observed in the normal men after sex steroid withdrawal and in the functional castrates.



Subjects and Methods

Normal (NL) men

Ten NL men (age range, 25–45 yr) participated in the study. All NL study subjects met the following criteria: 1) normal pubertal development, sexual function, and general health; 2) normal physical examination including a testicular volume 20 ml or more; 3) normal serum levels of T, E2, LH, FSH, TSH, and PRL; and 4) normal semen analysis according to WHO criteria [29] . Normal subjects represent the integrated model of both sex steroid and nonsteroidal components of gonadotropin negative feedback. Suppression of sex steroid synthesis in these subjects thus reveals the nonsteroidal input to FSH control.

Men with castrate T and Inh B levels

Three age-matched men (age range, 23–47 yr) with castrate levels of T and Inh B were also studied. Two patients were agonadal and thus true castrates; the first after a severe burn injury to the groin at the age of 10 yr, and the second after congenital unilateral torsion and contralateral reflex sympathetic orchiopathy. The third patient, who had Klinefelter syndrome, was not a true castrate, in that his testes were still present. However, we felt that it was appropriate to classify him as a functional castrate given a testes size of only 1 ml in association with a T level of 59 ng/dl (2.1 nmol/liter) and an undetectable Inh B level. All three patients had been off T replacement for at least 8 wk before participating in the study. Castrate men represent a model characterized by the complete absence of both gonadal sex steroids and nonsteroidal factors. Accordingly, they define the FSH levels that occur when the hypothalamic-pituitary axis is unrestrained by either component of gonadal feedback.

The study was approved by the human research committee at the Massachusetts General Hospital, and all subjects provided written informed consent.

Study protocol

Exp 1: neuroendocrine characterization of NL men before and after acute sex steroid suppression.

Subjects were admitted to the General Clinical Research Center of Massachusetts General Hospital at 1700 h and had an iv cannula inserted in a forearm vein. Commencing at 1800 h, blood sampling was performed every 10 min for 12 h, after which subjects were discharged home. On completion of the baseline frequent sampling study, an interval of at least 14 d was allowed to elapse before commencing sex steroid suppression due to blood volume considerations. Acute sex steroid withdrawal was induced in 10 NL men using high dose ketoconazole, an antifungal imidazole that blocks steroidogenesis predominantly by inhibiting C17–20 lyase [30] [31] . The ketoconazole regimen employed comprised a loading dose of 1 g at midnight, followed by a maintenance dose of 400 mg, four times daily, as previously described [24] . Because this dose of ketoconazole may impair cortisol biosynthesis, glucocorticoid replacement was provided in the form of dexamethasone (0.5 mg twice daily). We [19] and others [32] have demonstrated previously that this dose of dexamethasone does not suppress gonadotropin secretion in men. In view of the potential hepatotoxicity of ketoconazole [31] , liver function tests were monitored daily. Participants were withdrawn from the study if hepatic transaminases increased to greater than 3 times the upper limit of normal. The same 12-h frequent blood-sampling paradigm performed at baseline was repeated during h 66–78 (d 3) and 138–150 (d 6) of sex steroid ablation to define the extent and time course of changes in gonadotropin secretion during acute sex steroid ablation.

Exp 2: neuroendocrine characterization of men with castrate T and Inh B levels

In the three patients with castrate levels of T and Inh B, a more intensive sampling paradigm (every 5 min for 24 h) was employed given the importance of sampling interval and duration on analysis of pulsatile hormone secretion [33] [34] and the absence of blood volume considerations, as frequent sampling was performed on just one occasion.

In both Exp 1 and Exp 2, all samples were assayed for LH and free α-subunit (FAS), whereas FSH was measured in hourly samples. T and E2 levels were determined at baseline and at 6-h intervals during the study. Inh B was measured in a pool comprising equal aliquots of each sample obtained during the study. Mean LH and FSH levels were calculated for each frequent blood-sampling study. Pulsatile LH and FAS secretion were analyzed using a modification of the Santen and Bardin method [35] as previously validated by our group [36] .

Hormone assays

Serum LH and FSH concentrations were determined by microparticle enzyme immunoassay using the automated Abbott AxSYM system (Abbot Laboratories, Inc., Chicago, IL). The Second International Reference Preparation was used as the reference standard. The assay sensitivity for both LH and FSH was 1.6 mIU/ml. The intraassay coefficients of variation (CVs) for LH and FSH were less than 7% and less than 6%, respectively, with interassay CVs for both hormones of less than 7.4%. The reference range for gonadotropins in this assay was based on the 95% confidence limits of 36 NL men, aged 18–45 yr, and was 4.9–14.9 IU/liter for LH and 1.3–10.1 IU/liter for FSH. Serum FAS concentrations were determined by a monoclonal antibody RIA using highly purified α-subunit of hCG as the assay calibrator [37] . Serum T concentrations were measured using the Coat-A-Count RIA kit (Diagnostic Products, Los Angeles, CA), which has intra- and interassay CVs of less than 10% and a detection limit of 4 ng/dl. E2 was measured by the Abbott AxSYM system, which has an analytical sensitivity of 10 pg/ml, an intraassay CV of less than 6.4%, and an interassay CV of less than 10.6%. Inh B was measured using a commercially available, double antibody ELISA (Serotec, Oxford, UK) as previously described [25] . In our use, the clinical detection limit of this assay is 50 pg/ml, with a CV of 4–6% within plate and 15–18% between plates.

Statistical methods

In the NL men, mean hormone levels at baseline were compared with those during d 3 and 6 of sex steroid suppression using ANOVA for repeated measures followed by post-hoc Newman-Keuls testing for individual differences. The gonadotropin responses (mean LH and FSH levels, mean pulse frequency, and amplitude of both LH and FAS) of the NL men on d 6 of ketoconazole administration were compared with those in the castrate subjects using an unpaired t test. To correct for the different sampling paradigms employed, only data from samples drawn every 10 min for 12 h were included when comparing gonadotropin secretion in the functional castrates with that in the NL men after sex steroid ablation. P < 0.05 was taken to be statistically significant.



Results

Exp 1: neuroendocrine characterization of NL men before and after acute sex steroid suppression

One individual was withdrawn from the study on d 2 of ketoconazole administration because of a greater than 3-fold


5543
increase in hepatic transaminases, which returned to normal within 2 wk of discontinuation of the drug. The data reported are therefore for the nine subjects who completed 6 d of ketoconazole administration. Ketoconazole induced a fall to castrate levels of T [451 ± 20 to 38 ± 7 ng/dl (16 ± 1 to 1.4 ± 0.2 nmol/liter); P < 0.0005] and E2 [39 ± 4 to 15 ± 2 pg/ml (143 ± 15 to 55 ± 7 pmol/liter); P < 0.005] and a modest decrease in Inh B levels, which remained within the normal range (183 ± 19 to 136 ± 13 pg/ml; P < 0.005; Fig. 1 ). Suppression of sex steroids was associated with a more marked increase in mean LH (9.5 ± 0.9 to 24.9 ± 2.0 IU/liter; P < 0.0001) than FSH levels (5.1 ± 0.7 to 10.0 ± 1.5 IU/liter; P < 0.005; Fig. 1 ), with the latter remaining in the normal adult male range. Comparison of mean gonadotropin levels on d 3 vs. d 6 of ketoconazole administration reveled no significant differences (26.2 ± 2.2 vs. 24.9 ± 2.0 IU/liter for LH and 8.6 ± 1.2 vs. 10.0 ± 1.5 IU/liter for FSH, respectively); therefore, only the d 6 data are presented in the figures. GnRH pulse frequency increased, as evidenced by a decrease in interpulse interval [IPI; 167 ± 28 vs. 90 ± 17 min for LH ( P < 0.05) and 169 ± 25 vs. 55 ± 4 min for FAS ( P < 0.005)]. There was no change in LH pulse amplitude (6.2 ± 1.3 vs. 4.9 ± 0.6 IU/liter; P = NS), whereas FAS pulse amplitude increased from 86.2 ± 11.3 to 196.4 ± 30.9 IU/liter ( P < 0.005).

Exp 2: neuroendocrine characterization of men with castrate T and Inh B levels

The castrate subjects had a mean T level of 66 ± 8 ng/dl (2 ± 0.4 nmol/liter), an E2 level of 20 ± 1 pg/ml (73 ± 4pmol/liter),


Figure 1. Hormonal profile of 9 normal men at baseline and in response to gonadal steroid withdrawal induced by the administration of ketoconazole for 150 h. , Mean ± SEM data for the group; ■, individual data. Asterisks represent a significant change from mean baseline values: *, P < 0.05; **, P < 0.0005. The shaded area represents the 95% confidence limits for 36 normal men, aged 18–45 yr. To convert the values for T to nanomoles per liter, multiply by 0.03467. To convert the values for E2 to picomoles per liter, multiply by 3.671.

undetectable Inh B levels (<50 pg/ml), an LH level of 67.2 ± 20.1 IU/liter, and a FSH level of 59.5 ± 17.7 IU/liter. Despite having a similar sex steroid milieu, the mean FSH levels observed in NL men after sex steroid ablation were approximately 6-fold lower than those seen in the castrate subjects (10.0 ± 1.5 vs. 59.5 ± 17.7 IU/liter; P < 0.0005; Fig. 2 ). In contrast, mean LH levels in the NL men were less than 3-fold lower than those in castrate subjects (24.9 ± 2.0 vs. 66.8 ± 20.1 IU/liter; P < 0.005; Fig. 2 ). The mean GnRH pulse frequency tended to be faster if FAS rather than LH were used as the surrogate marker of GnRH secretion (IPI of 34.6 ± 2.3 vs. 47.5 ± 6.0 min, respectively; P = 0.07). When the data were analyzed comparably ( i.e. employing a 10-min sampling interval for 12 h), there was no difference between the GnRH pulse frequency in the NL men on d 6 of sex steroid suppression and that in the castrate subjects whether either LH (IPI of 77 ± 2 vs. 90 ± 17 min) or FAS (52 ± 4 vs. 55 ± 4 min) was used as the marker of GnRH.



Discussion

Using an in vivo human model of short-term gonadal steroid withdrawal, this study demonstrates that selective ablation of sex steroids results in only a modest increase in FSH levels, which remain within the normal adult male range, implying that a nonsteroidal factor, presumably Inh B, is likely to be the major regulator of FSH secretion in the human male.

Most of the literature on FSH regulation in the human has focused on the sex steroid component of gonadal feedback.


5544


Figure 2. Comparison of the gonadotropin concentrations in normal men at baseline () and in response to sex steroid withdrawal () with those in functional castrates (■). Asterisks represent a significant difference from the baseline values of normal men (*, P < 0.05; **, P < 0.0005). The dashed line represents the upper 95th confidence limit for 36 normal men, aged 18–45 yr.

Previous studies from our group focused on determining the relative importance of T vs. E2 to FSH regulation using in vivo human models of selective sex steroid withdrawal (selective E2 suppression achieved by aromatase inhibition, on the one hand, vs. suppression of both T and E2 with ketoconazole, on the other) [24] . These studies demonstrated that in terms of sex steroid feedback, E2 is the major regulator of FSH in the male [24] . In eugonadal men, the suppressive effects of pharmacological doses of sex steroids on FSH secretion have been established unequivocally [15] [16] [17] [18] [19] [20] [21] [22] . However, in subjects with primary gonadal failure, sex steroid administration alone fails to reduce FSH levels to the normal range [18] [38] [39] , pointing to a major role for a nonsteroidal factor in FSH regulation. Therefore, the focus of the present studies was to determine the relative importance of sex steroids vs. Inh B to FSH regulation in the human.

The concept of dual endocrine activity of the testis was first proposed more than 65 yr ago with the demonstration that administration of an aqueous testicular extract to gonadectomized male rats could suppress the formation of castration cells in the anterior pituitary, suggesting a physiological role for a nonsteroidal gonadal secretory product [40] . Over the last several decades, efforts to explore inhibin physiology in the human have been hampered by numerous methodological difficulties, including the lack of inhibin for human administration [13] . For this reason studies on inhibin physiology in the human have, of necessity, been indirect and inferential. There is now an abundance of literature attesting to the importance of Inh B as an important endocrine feedback regulator of FSH secretion in the human male [8] [9] [10] [11] [41] [42] . However, the relative importance of Inh B vs. sex steroids to FSH control in the human has not been established.

In the present study short-term, reversible sex steroid withdrawal with ketoconazole was employed to isolate the sex steroid and nonsteroidal components of FSH feedback. Clearly, the duration of castration is an important limitation of this study, in that the impact of acute sex steroid ablation is being compared with that of longer term castration. Although there are few data on the time course of the gonadotropin rise after gonadectomy in the human male, studies in the monkey suggest that gonadotropins reach stable castrate levels approximately 20 d after orchidectomy [43] . Although our sequential frequent sampling studies demonstrated that gonadotropin levels had actually reached a plateau during the 1-wk period of ketoconazole administration, it is possible that a further secondary rise in gonadotropins would have been observed had the duration of castration been extended. However, in a study of nine men with prostate cancer treated with a similar ketoconazole regimen for 12 months, no significant change was observed in FSH levels, whereas LH levels continued to rise until approximately 60 d [44] . Although neither LH nor FSH reached castrate levels in the short window of sex steroid ablation employed in this study, a differential gonadotropin response was already clearly apparent, such that LH had increased to approximately 40% of castrate levels, whereas FSH remained at only approximately 15% of castrate levels. The fact that removal of sex steroid negative feedback caused LH levels to increase well above the normal adult male range compared with a modest rise in FSH that did not exceed normal levels thus points to an important role of Inh B in FSH regulation. The modest increase in FSH is all the more significant given the 25% decrease in Inh B levels observed in this study, which is also likely to have contributed to the FSH rise given the known correlation between Inh B and FSH in normal men [8] [45] [46] .

The impact of inhibin administration [47] [48] [49] [50] and immunoneutralization [51] [52] [53] on FSH levels has been examined in a variety of animal models. However, one must be cautious about extrapolating data from nonprimates to the human given the species differences that have been observed in FSH regulation. Thus, although administration of inhibin antiserum results in an increase in FSH levels in the adult male rhesus monkey [52] , no effect on FSH is observed in the adult male rat [53] . Support for the hypothesis that Inh B is likely to be the most important regulator of FSH secretion in the human male is provided by a series of elegant studies in the monkey demonstrating that only the institution of combined treatment with T and gonadal peptides derived from charcoal-extracted porcine follicular fluid prevents the postcastration rise in FSH [48] . Selective withdrawal of follicular fluid treatment then results in a dramatic rise in serum FSH levels, which returns to normal once therapy with gonadal peptides is restored. Subsequent studies performed after inhibin had


5545
been purified and isolated confirmed that the biologically active gonadal peptide present in the follicular fluid was indeed inhibin [49] . Although in retrospect these studies employed pharmacological doses of inhibin A [12] , and it is now known that it is Inh B that is the physiologically relevant form of inhibin in the male [8] [12] [54] , there are no data to suggest that the potencies of Inh A and B differ.

It is interesting that ablation of sex steroids caused an approximately 25% reduction in Inh B levels despite a 2-fold increase in FSH levels as we have previously reported [24] . These data are in keeping with the hypothesis that the negative feedback effect of Inh B on FSH secretion is more robust than the positive stimulating effect of FSH on Inh B secretion [55] . The mechanism for the decline in Inh B after biochemical castration is unclear. Potential explanations are that lack of T or E2 either directly affects Sertoli cell production of Inh B or, alternatively, interferes with spermatogenesis and thus the paracrine regulation of inhibin by germ cells [56] [57] [58] . It is possible, therefore, that transient disruption of spermatogenesis at the spermatid stage resulting from castrate levels of T during the period of ketoconazole administration led to the decrease in Inh B levels observed in this study. It also possible that ketoconazole may have had a direct suppressive effect on Inh B secretion independent of its effect to lower T levels. However, given the rapid fall in T after administration of the loading dose of ketoconazole, it is impossible to distinguish between these two effects.

Concerning the GnRH pulse frequency estimations in these studies, two important conclusions can be made. First, when a comparable sampling paradigm is used, a similar GnRH pulse frequency is observed in normal men after sex steroid withdrawal and in functional castrates, indicating that GnRH pulse frequency is regulated by sex steroids rather than by Inh B. Second, using FAS as a marker of GnRH pulse frequency, pulses of GnRH occur approximately every 35 min in castrate men, indicating that the true castrate frequency is significantly faster than what we and others proposed based on analysis of LH pulsatility [18] [59] . In future experiments it will be interesting to examine the impact on FSH secretion of increasing GnRH pulse frequency to castrate levels using the model of GnRH-deficient men in whom sex steroid secretion has been blocked with ketoconazole.

Using the acute model of ketoconazole-induced gonadal steroid withdrawal, we demonstrated that suppression of sex steroids in normal men results in increases in LH, but not FSH, to levels above the normal range. From these experiments we infer that a nonsteroidal gonadal factor, most likely Inh B, is a major regulator of FSH in the human male. Confirmation of this hypothesis awaits the availability of inhibin for human administration.

Acknowledgments

We gratefully acknowledge the nurses of the General Clinical Research Center for their excellent clinical care, and the technicians of the Reproductive Endocrine Sciences Center RIA Core for their superb technical contributions to this study.

References


1. Howards SS 1995 Treatment of male infertility. N Engl J Med 332:312–317   Citation

2. Kumar TR, Wang Y, Lu N, Matzuk MM 1997 Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201–204   Abstract

3. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P 1998 Impaired follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95:13612–13617   Abstract

4. Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT 1997 Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 15:205–206   Abstract

5. Phillip M, Arbelle JE, Segev Y, Parvari R 1998 Male hypogonadism due to a mutation in the gene for the β-subunit of follicle-stimulating hormone. N Engl J Med 338:1729–1732   Citation

6. Lindstedt G, Nystro E, Matthews C, Ernst I, Janson PO, Chaterjee K 1998 Follitropin (FSH) deficiency in an infertile male due to FSH-β mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med 36:663–665   Abstract

7. Dubey AK, Zeleznik AJ, Plant TM 1987 In the rhesus monkey ( Macaca mulatta), the negative feedback regulation of follicle-stimulating hormone secretion by an action of testicular hormone directly at the level of the anterior pituitary gland cannot be accounted for by either testosterone or estradiol. Endocrinology 121:2229–2237   Abstract

8. Illingworth PJ, Groome NP, Byrd W, Rainey WE, McNeilly AS, Mather JP, Bremner WJ 1996 Inhibin B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 81:1321–1325   Full Text

9. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, Bremner WJ 1996 Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 81:3341–3345   Full Text

10. Nachtigall LB, Boepple PA, Seminara SB, Khoury RH, Sluss PM, Lecain AE, Crowley Jr WF 1996 Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and after long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment-a clinical research center study. J Clin Endocrinol Metab 81:3520–3525   Full Text

11. Seminara SB, Boepple PA, Nachtigall LB, Pralong FP, Khoury RH, Sluss PM, Lecain AE, Crowley Jr WF 1996 Inhibin B in males with gonadotropinreleasing hormone (GnRH) deficiency: changes in serum concentrations after short term physiologic GnRH replacement-a clinical research center study. J Clin Endocrinol Metab 81:3692–3696   Full Text

12. Plant TM, Padmanabhan V, Ramaswamy S, McConnell DS, Winters SJ, Groome N, Midgley Jr AR 1997 Circulating concentrations of dimeric inhibin A and B in the male rhesus monkey ( Macaca mulatta). J Clin Endocrinol Metab 82:2617–2621   Full Text

13. Hayes FJ, Hall JE, Boepple PA, Crowley Jr WF 1998 Differential regulation of gonadotropin secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab 83:1835–184   Full Text

14. Ying S-Y 1988 Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9:267–293   Abstract

15. Sherins RJ, Loriaux DL 1973 Studies on the role of sex steroids in the feedback control of FSH concentrations in men. J Clin Endocrinol Metab 36:886–893   Citation

16. Santen RJ 1975 Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men. J Clin Invest 56:1555–1563   Abstract

17. Winters SJ, Janick JJ, Loriaux DL, Sherins RJ 1979 Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. II. Use of the estrogen antagonist, clomiphene citrate. J Clin Endocrinol Metab 48: 222–227   Citation

18. Matsumoto AM, Bremner WJ 1984 Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab 58:609–614   Abstract

19. Finkelstein JS, Whitcomb RW, O'Dea LSL, Longcope C, Schoenfeld DA, Crowley Jr WF 1991 Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone deficient men. J Clin Endocrinol Metab 73:609–620   Abstract

20. Finkelstein JS, O'Dea LSL, Whitcomb RW, Crowley Jr WF 1991 Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone deficient men. J Clin Endocrinol Metab 73:621–628   Abstract

21. Veldhuis JD, Rogol AD, Samojlik E, Ertel NH 1984 Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J Clin Invest 74:47–55   Abstract
5546


22. Bagatell CJ, Gahl KD, Bremner WJ 1994 The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl 15:15–21   Abstract

23. Hayes FJ, Seminara SB, DeCruz S, Boepple PA, Crowley Jr WF 2000 Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 85:3027–3035   Full Text

24. Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley Jr WF 2001 Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle stimulating hormone secretion. J Clin Endocrinol Metab 86:53–58   Full Text

25. Groome KP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81:1401–1405   Full Text

26. Spratt DI, Finkelstein JS, Butler JP, Badger TM, Crowley Jr WF 1987 Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J Clin Endocrinol Metab 64:1179–1186   Abstract

27. Finkelstein JS, Badger TM, O'Dea LStL, Spratt DI, Crowley WF 1988 Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-deficient men and perifused rat pituitary cells. J Clin Invest 81:1725–1733   Abstract

28. Wu FC, Wallace EM, Howe DC, Kacser EM, Sellar RE 1991 Effects of decreasing exogenous GnRH pulse frequency on FSH and inhibin secretion in men with idiopathic hypogonadotropic hypogonadism. Acta Endocrinol (Copenh) 125:138–145   Abstract

29. WHO 1992 WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 3rd Ed. Cambridge: Cambridge University Press  

30. De Coster R, Caers I, Coene MC, Amery W, Beerens D, Haelterman C 1986 Effects of high dose ketoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostate cancer patients. Clin Endocrinol (Oxf) 24:657–664   Abstract

31. Sonino N 1987 The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 317:812–818   Citation

32. Veldhuis JD, Lizarralde G, Iranmanesh A 1992 Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J Clin Endocrinol Metab 74:96–102   Abstract

33. Crowley Jr WF, Filicori M, Spratt DI, Santoro NF 1985 The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41:473–526   Citation

34. Veldhuis JD, Evans WS, Johnson ML, Wills MR, Rogol AD 1986 Physiological properties of the luteinizing hormone pulse signal: impact of intensive and extended venous sampling paradigms on its characterization in healthy men and women. J Clin Endocrinol Metab 62:881   Abstract

35. Santen RJ, Bardin CW 1973 Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest 52:2617–2628   Citation

36. Hayes FJ, McNicholl DJ, Schoenfeld D, Marsh EE, Hall JE 1999 Free α subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab 84:1028–1036   Full Text

37. Landy H, Schneyer AL, Whitcomb RW, Crowley Jr WF 1990 Validation of highly specific and sensitive radioimmunoassays for lutropin, follitropin and free alpha subunit in unextracted urine. Clin Chem 36:340–344   Abstract

38. Capell PT, Paulsen CA, Derleth D, Skoglund R, Plymate S 1973 The effects of short-term testosterone administration on serum FSH, LH, and testosterone levels: evidence for selective abnormality in LH control in patients with Klinefelter's syndrome. J Clin Endocrinol Metab 37:752–759   Citation

39. Winters SJ, Sherins RJ, Loriaux DL 1979 Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. III. Androgen resistance in primary gonadal failure. J Clin Endocrinol Metab 48:553–558   Citation

40. McCullagh DR 1932 Dual endocrine activity of the testes. Science 76:19–20  

41. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE 1997 Serum inhibin B in healthy pubertal and adolescent boys; relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 82:3976–3981   Full Text

42. Wallace EM, Groome NP, Riley SC, Parker AC, Wu FCW 1997 Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab 82:3111–3115   Full Text

43. Resko JA, Quadri SK, Spies HG 1977 Negative feedback control of gonadotropins in male rhesus monkeys: effects of time after castration and interactions of testosterone and estradiol. Endocrinology 101:215–224   Citation

44. Heyns W, Drochmans A, Van der Schueren E, Verhoeven G 1985 Endocrine effects of high-dose ketoconazole therapy in advanced prostate cancer. Acta Endocrinol (Copenh) 110:276–283   Abstract

45. Byrd W, Bennett MJ, Carr BR, Dong Y, Wians F, Rainey W 1998 Regulation of biologically active dimeric inhibin A and B from infancy to adulthood in the male. J Clin Endocrinol Metab 83:2849–2854   Full Text

46. Anderson RA, Wallace EM, Groome NP, Bellis AJ, Wu RCW 1997 Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotropin suppression by exogenous testosterone. Hum Reprod 12:746–751   Abstract

47. Tilbrook AJ, de Kretser DM, Clarke IJ 1993 Human recombinant inhibin A suppresses plasma follicle stimulating hormone to intact levels but has no effect on luteinizing hormone in castrated rams. Biol Reprod 49:779–788   Abstract

48. Abeyawardene SA, Plant TM 1989 Institution of combined treatment with testosterone and charcoal-extracted porcine follicular fluid immediately after orchidectomy prevents the postcastration hypersecretion of follicle-stimulating hormone in the hypothalamus-lesioned monkey ( Macaca mulatta) receiving an invariant intravenous gonadotropin-releasing hormone infusion. Endocrinology 124:1310–1318   Abstract

49. Majumdar SS, Mikuma N, Ishwads PC, Winters SJ, Attardi BJ, Perera AD, Plant TM 1995 Replacement with recombinant human inhibin immediately after orchidectomy in the hypophsiotropically clamped male rhesus monkey ( Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSHβ messenger ribonucleic acid levels at precastration values. Endocrinology 136:1969–1977   Abstract

50. Ramaswamy S, Pohl CR, McNeilly AS, Winters SJ, Plant TM 1998 The time course of follicle-stimulating hormone suppression by recombinant human inhibin A in the adult male rhesus monkey ( Macaca mulatta). Endocrinology 139:3409–3415   Abstract

51. Medhamurthy R, Abeyawardene SA, Culler MD, Negro-Vilar A, Plant TM 1990 Immunoneutralization of circulating inhibin in the hypophsiotropically clamped male rhesus monkey ( Macaca mulatta) results in a selective hypersecretion of follicle-stimulating hormone. Endocrinology 126:2116–2124   Abstract

52. Medhamurthy R, Culler MD, Gay VL, Negro-Vilar A, Plant TM 1991 Evidence that inhibin plays a major role in the regulation of follicle-stimulating hormone secretion in the fully adult male rhesus monkey ( Macaca mulatta). Endocrinology 129:389–395   Abstract

53. Culler MD, Negro-Villar A 1988 Passive immunoneutralization of endogenous inhibin: sex related differences in the role of inhibin during development. Mol Cell Endocrinol 58:263–273   Abstract

54. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley Jr WF, Schneyer AL 1994 Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 79:45–50   Abstract

55. Ramaswamy S, Marshall GR, McNeilly AS, Plant TM 2000 Dynamics of the follicle-stimulating hormone (FSH)-inhibin B feedback loop and its role in regulating spermatogenesis in the adult male rhesus monkey ( Macaca mulatta) as revealed by unilateral orchidectomy. Endocrinology 141:18–27   Abstract

56. Pineau C, Sharpe RM, Saunders PTK, Gerard N, Jegou B 1990 Regulation of Sertoli cell inhibin production and of inhibin α-subunit mRNA levels by specific germ cell types. Mol Cell Endocrinol 72:13–22   Abstract

57. Depuydt CE, Mahmoud AM, Dhooge WS, Schoonjans FA, Comhaire FH 1999 Hormonal regulation of inhibin B secretion by immature rat Sertoli cells in vitro: possible use as a bioassay for estrogen detection. J Androl 20:54–62   Abstract

58. Foresta C, Bettella A, Rossato M, La Sala G, De Paoli M, Plebani M 1999 Inhibin B plasma concentrations in oligospermic subjects before and after therapy with follicle stimulating hormone. Hum Reprod 14:906–912   Abstract

59. Bhasin S, Krummen LA, Swerdloff RS, et al. 1989 Stage dependent expression of inhibin α- and β-B subunits during the cycle of the rat seminiferous epithelium. Endocrinology 124:987–991   Abstract

60. Winters SJ, Troen P 1983 A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab 57:432–435   Abstract